Phase 2 Alzheimer s Disease Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Alzheimer s Disease
AbbVie210 enrolled10 locationsNCT07599670
Recruiting
Phase 1Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Alzheimer s DiseaseBeta-AmyloidProdromal Alzheimer's Disease+2 more
AC Immune SA304 enrolled26 locationsNCT05462106
Recruiting
Phase 2
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Weill Medical College of Cornell University20 enrolled1 locationNCT07553338
Recruiting
Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer s Disease
Novartis Pharmaceuticals407 enrolled65 locationsNCT07094516
Recruiting
Phase 2
Fisetin in Mild Alzheimer's Disease
Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+4 more
Sunnybrook Health Sciences Centre5 enrolled1 locationNCT07279714
Recruiting
Phase 2
Open-label Extension Study in Participants With Early Alzheimer's Disease
Alzheimer s Disease
GlaxoSmithKline220 enrolled33 locationsNCT07105709
Recruiting
Phase 1Phase 2
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
Multiple SclerosisAlzheimer s Disease
Brigham and Women's Hospital250 enrolled1 locationNCT02649985
Recruiting
Phase 2
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+3 more
Sunnybrook Health Sciences Centre12 enrolled1 locationNCT07279740
Recruiting
Phase 2
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
Alzheimer s DiseaseMCIMCI-AD, Early Stage Alzheimer's Disease
Medical University of Lodz30 enrolled1 locationNCT06850597
Recruiting
Phase 2
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Alzheimer s Disease
Shanghai Hengrui Pharmaceutical Co., Ltd.45 enrolled1 locationNCT06199037